Spinogenix, Inc. — Form D
Spinogenix, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-21. The offering totals $25.0M, of which $2.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-06-21
- Form: D
- Accession: 0001718198-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $2.8M
- Remaining: $22.2M
- Investors: 3
- Date of first sale: 2024-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-516626
Issuer
- Name: Spinogenix, Inc.
- CIK: 0001718198
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1801 CENTURY PARK EAST, SUITE 2400, LOS ANGELES, CA, 90067
- Phone: (310) 853-5695
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Stella Sarraf | Director | Los Angeles, CA |
| Jerre Whitney Stead | Director | Los Angeles, CA |
| Mervyn Whitney Turner | Director | Los Angeles, CA |
| Dan Whitney Albosta | Executive Officer | Los Angeles, CA |
| Stella Sarraf | Executive Officer | Los Angeles, CA |
| Peter Whitney Vanderklish | Executive Officer | Los Angeles, CA |
| Steve Young | Director | DELAFIELD, WI |
| Vincent Simmon | Director | La Jolla, CA |
| Vincent Simmon | Executive Officer | La Jolla, CA |
| Franz Hefti | Director | San Diego, CA |
| Peter Vanderklish | Executive Officer | San Diego, CA |
| Josh Swartz | Director | SAN DIEGO, CA |
| Stella Sarraf, Ph.D. | Director | Los Angeles, CA |
| Stella Sarraf, Ph.D. | Executive Officer | Los Angeles, CA |
| Jerre L. Stead | Director | Los Angeles, CA |
| Mervyn Turner, Ph.D. | Director | Los Angeles, CA |
Other filings by this issuer (8)
More